Extending Survival After Inoperable Pancreatic Cancer
Surgical resection of adenocarcinoma can significantly improve survival, but only 20% of patients...
Read More
chemotherapy
New Guidelines for Head & Neck Cancer Reirradiation
Recurrent and second primary head-and-neck squamous cell carcinomas (HNSCC) arising within or close to previously irradiated areas are a significant clinical challenge. Salvage surgical resection is the standard of care, but...
Read MoreAgent Approved for Highly Toxic Chemotherapy Levels
The FDA has approved glucarpidase (Voraxaze, BTG International) for treating patients with toxic levels of methotrexate—a type of chemotherapy—in the blood due to kidney failure. The drug breaks down methotrexate to a form that...
Read MoreA New Guide for Using Antiemetics
A significant proportion of all cancer patients experience nausea or vomiting during the course of their treatment. Nausea and vomiting have long been common adverse effects from certain types of cancer therapy and can lead to...
Read MoreThe Impact of Complications on Colorectal Cancer Care
Colorectal cancer (CRC) is diagnosed in almost 150,000 patients in the United States each year and is the second leading cause of cancer-related death, accounting for more than 50,000 mortalities annually. The use of adjuvant...
Read More
